24IA2E2E10D5 [24IA2]
24IA2E2E10D5 [24IA2]
规格:
货期:
编号:TS212976
品牌:Testobio
| 产品名称： | 24IA2E2E10D5 24IA2 |
|---|---|
| 商品货号： | TS212976 |
| Organism： | Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma) |
| Cell Type： | hybridoma: B lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease： | Leukemia |
| Applications： | The antibody reacts with the A, B, C, AB and ABC strains of FeLV. |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Derivation： | Animals were immunized with purified FeLV p27. Spleen cells were fused with Sp2/0-Ag14 myeloma cells. |
| Genes Expressed： | immunoglobulin; monoclonal antibody; against the p27 protein of Feline Leukemia virus (FeLV) |
| Cellular Products： | immunoglobulin; monoclonal antibody; against the p27 protein of Feline Leukemia virus (FeLV) |
| Tumorigenic： | Yes |
| Effects： | Yes, forms ascites in pristane primed BALB/c mice |
| Comments： | Animals were immunized with purified FeLV p27. Spleen cells were fused with Sp2/0-Ag14 myeloma cells. The antibody reacts with the A, B, C, AB and ABC strains of FeLV. The antibody does not react with RD114 virus or AKR Murine Leukemia virus (MuLV). |
| Complete Growth Medium： | The base medium for this cell line is ATCC-formulated Dulbeccos Modified Eagles Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
|
| Subculturing： | Medium Renewal: Every 2 to 3 days Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml. |
| Isotype： | IgG |
| Name of Depositor： | Regents of the University of California |
| Deposited As： | mouse (B cell); mouse (myeloma) |
| U.S. Patent Number： | |
| References： | Lutz H. Hybridomas producing monoclonal antibodies specific for FeLV p27. US Patent 4,713,325 dated Dec 15 1987 |
首页 >
产品中心
>
微生物培养
>
菌株
>
null
>
24IA2E2E10D5 [24IA2]
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | 24IA2E2E10D5 24IA2 |
|---|---|
| 商品货号： | TS212976 |
| Organism： | Mus musculus (B cell); Mus musculus (myeloma), mouse (B cell); mouse (myeloma) |
| Cell Type： | hybridoma: B lymphocyte |
| Product Format： | frozen |
| Morphology： | lymphoblast |
| Culture Properties： | suspension |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease： | Leukemia |
| Applications： | The antibody reacts with the A, B, C, AB and ABC strains of FeLV. |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Derivation： | Animals were immunized with purified FeLV p27. Spleen cells were fused with Sp2/0-Ag14 myeloma cells. |
| Genes Expressed： | immunoglobulin; monoclonal antibody; against the p27 protein of Feline Leukemia virus (FeLV) |
| Cellular Products： | immunoglobulin; monoclonal antibody; against the p27 protein of Feline Leukemia virus (FeLV) |
| Tumorigenic： | Yes |
| Effects： | Yes, forms ascites in pristane primed BALB/c mice |
| Comments： | Animals were immunized with purified FeLV p27. Spleen cells were fused with Sp2/0-Ag14 myeloma cells. The antibody reacts with the A, B, C, AB and ABC strains of FeLV. The antibody does not react with RD114 virus or AKR Murine Leukemia virus (MuLV). |
| Complete Growth Medium： | The base medium for this cell line is ATCC-formulated Dulbeccos Modified Eagles Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
|
| Subculturing： | Medium Renewal: Every 2 to 3 days Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml. |
| Isotype： | IgG |
| Name of Depositor： | Regents of the University of California |
| Deposited As： | mouse (B cell); mouse (myeloma) |
| U.S. Patent Number： | |
| References： | Lutz H. Hybridomas producing monoclonal antibodies specific for FeLV p27. US Patent 4,713,325 dated Dec 15 1987 |
